drugset / Trial / NCT01195831
Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the clinical efficacy of once daily treatment for 4 weeks with Xamiol® gel (calcipotriol plus betamethasone) with twice daily treatment for 4 weeks with Calcipotriol Scalp Solution in patients with scalp psoriasis.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Betamethasone | Other / unclassified | 0.05 % | — |
| Comparator | Calcipotriol | Small molecule | 0.005 % | — |
| Comparator | Calcipotriol | Small molecule | 0.05 mg/ml | — |